Effects of prenatal tobacco and cannabis exposure on child development
Prenatal Tobacco and Cannabis Exposure: A Translational Study
This study looks at how being exposed to tobacco and cannabis while in the womb affects children's growth and health, and it's for parents who want to understand the long-term effects of these substances on their kids.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of New York at Buffalo NIH-funded |
| Lab location | 1 site (Amherst, United States) |
| Project ID | NIH-10690631 on NIH RePORTER |
What this research studies
This research investigates how exposure to tobacco and cannabis during pregnancy affects child development and health outcomes. It involves studying a group of children who were exposed to these substances in utero, comparing them to demographically matched controls. The study uses both human participants and animal models to explore the mechanisms behind these effects, focusing on body weight, behavior, and cognitive function. By collecting data from early pregnancy through childhood, the research aims to provide insights into the long-term impacts of prenatal substance exposure.
Who could benefit from this research
Good fit: Ideal candidates for this research include pregnant individuals who use tobacco and/or cannabis and their children.
Not a fit: Patients who are not pregnant or who have not been exposed to tobacco or cannabis during pregnancy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and interventions for children affected by prenatal substance exposure.
How similar studies have performed: Previous research has shown significant effects of prenatal substance exposure on child development, indicating that this approach is built on established findings.
Where this research is happening
Amherst, United States
- State University of New York at Buffalo — Amherst, United States (Active)
Researchers
- Principal investigator: Thanos, Panayotis K — State University of New York at Buffalo
- Study coordinator: Thanos, Panayotis K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.